Vimarsana
Biggest News Aggregation in the World

Page 8 - With Inputs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from With Inputs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In With Inputs Today - Breaking & Trending Today

Ayodhya DM adjusts school timings from 10 am to 3 pm due to severe cold weather - Vimarsana News

Ayodhya DM adjusts school timings from 10 am to 3 pm due to severe cold weather

Due to severe cold weather, school timings in Ayodhya have been adjusted from 10 am to 3 pm until February 3. Necessary arrangements will be made to protect students from the cold.

Bigg Boss 17 Finale: Friends enter house to support finalists; astrologers predict top 2 - Vimarsana News

Bigg Boss 17 Finale: Friends enter house to support finalists; astrologers predict top 2

Bigg Boss 17 is set to have its finale tomorrow, and ahead of the grand day, support from outside has arrived to back the Top 5 contestants

Kunal Kemmu says 'Shaadi ka Happy Birthday' as he wishes wifey Soha Ali Khan, watch the video that has gone viral! - Vimarsana News

Kunal Kemmu says 'Shaadi ka Happy Birthday' as he wishes wifey Soha Ali Khan, watch the video that has gone viral!

Kunal Kemmu posted a video on Instagram which he captioned ’Shaadi ka Happy Birthday’. Many Industry members like Kareena Kapoor and Neha Dhupia wished them too

Bears maul Indian Market: Top 5 Indian firms shed ₹1.67 lakh crore, HDFC Bank leads tumble - Vimarsana News

Bears maul Indian Market: Top 5 Indian firms shed ₹1.67 lakh crore, HDFC Bank leads tumble

Among top 10 firms, Reliance Industries, TCS, HDFC Bank, Hindustan Unilever, and SBI saw a reduction in their valuation, while ICICI Bank, Infosys, Bharti Airtel, LIC, and ITC emerged as gainers.

Sun Pharma to buy remaining stake in Taro Pharma for $347.8 million - Vimarsana News

Sun Pharma to buy remaining stake in Taro Pharma for $347.8 million

Sun Pharmaceutical Industries plans to acquire all outstanding shares of Taro Pharmaceutical Industries for $43 per share in cash, aiming to gain complete control over its subsidiary